Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions | Blood Cancer Journal
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
IACH on X: "Join us TODAY at 2pm Eastern Time (Atlanta), 8pm CET (Paris) for live news from #ASH21 with Dr. Salomon Manier and @Mohty_EBMT Register Free here: https://t.co/bdQmP2b0TS https://t.co/oYQD70BBZf" / X
CHU de Lille: avancée majeure espérée dans le traitement du cancer de la moelle osseuse - La Voix du Nord
The CARAMBA team | CARAMBA
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Dana-Farber Cancer Institute - Photo Gallery - Ghobrial Lab - Precursor Hematological Malignancies
Optimal strategies to manage late-stage multiple myeloma: the promise of anti-BCMA therapies | VJHemOnc
L'ARC soutient les recherches menées à l'IRCL - IRCL
Pr Salomon MANIER - Auteur | Edimark
Post-Congress webinars – International Academy for Clinical Hematology (IACH)
Primary refractory young myeloma: a difficult clinical situation - YouTube
☎️ Contacts du Dr Salomon Manier, Hematologue à Lille 59000
Actus Congrès - Chicago 2022 - j3 - Tribune'K Hemato
Salomon Manier | Videos & Research | VJHemOnc
Molecular prognostication in SMM - YouTube
Henri GUÉRARD (1846-1897): Salomon, maniere-noire, mezzotint — Armstrong Fine Art
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Pr Salomon MANIER - Auteur | Edimark
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
Salomon MANIER, auteur sur Horizons Hémato
